Medical Policy Updates
- NewSynthetic Cartilage Implants for Joint Pain
- NewEsketamine (Spravato)
- NewHemophilia Products - Congenital Factor VIII (Hemophilia A) with or without inhibitors: Hemlibra
- NewHemophilia Products – Congenital Factor XIII A-Subunit Deficiency: Tretten
- NewHemophilia Products - Congenital Factor XIII Deficiency: Corifact
- NewHemophilia Products – Factor IX (Hemophilia B): Alphanine SD, Alprolix, Bebulin, Benefix, Idelvion, Ixinity, Mononine, Profilnine, Rebinyn, and Rixubis
- NewHemophilia Products - Factor VIII (Hemophilia A) and Factor IX (Hemophilia B) with inhibitors, Acquired Hemophilia, Congenital Factor VII Deficiency, and Glanzmann’s Thrombasthenia: Novoseven RT
- NewHemophilia Products - Factor VIII (Hemophilia A) and Factor IX (Hemophilia B) with Inhibitors: Feiba NF
- NewHemophilia Products - Factor VIII (Hemophilia A) and Von Willebrand disease (VWD): Alphanate and Humate-P
- NewHemophilia Products – Factor VIII (Hemophilia A, Congenital and Acquired): Advate, Adynovate, Afstyla, Eloctate, Helixate FS, Hemofil M, Koate-DVI, Kogenate FS, Kovaltry, Monoclate-P, Novoeight, NUWIQ, Recombinate, Xyntha, Obizur, Jivi and Esperoct
- NewHemophilia Products - Factor X: Coagadex
- NewHemophilia Products – von Willebrand Factor (von Willebrand Disease): Wilate and Vonvendi
- RevisedBioengineered Skin and Soft Tissue Substitutes
- RevisedCapsaicin 8% patch (Qutenza)
- RevisedHistone Deacetylase Inhibitor(s) [Romidepsin (Istodax®)]
- RevisedHome Positive Pressure Ventilation in Adults
- RevisedIntravenous Antibiotic Therapy for Lyme Disease
- RevisedTopotecan Hydrochloride (Hycamtin) Injection
- RevisedPlacement of Iliac Vein Stent
- RevisedGonadotropin-Releasing Hormone (GnRH) Receptor Antagonist [Degarelix (Firmagon™)]
- RevisedDrug Testing in Pain Management and Substance Use Disorder Treatment Settings
- RevisedDermatologic Applications of Photodynamic Therapy
- RevisedVoretigene neparvovec-rzyl (Luxturna)
- RevisedAlkylating Agent(s) [Temozolomide intravenous (Temodar®)]
- RevisedRadiation Treatment with Azedra (Iobenguane I-131)
